Literature DB >> 9557442

Antibiotic resistance of prevalent Salmonella and Shigella strains in northwest Ethiopia.

A Aseffa1, E Gedlu, T Asmelash.   

Abstract

Salmonella and Shigella strains were isolated prospectively from in- and outpatient specimens of the Gondar College teaching hospital over a two year period, from June 1994 to May 1996. Of 7993 miscellaneous specimens cultured, 80 yielded Salmonella and 147 Shigella. Serogroup B dominated among the salmonella, accounting for 61% of isolates, followed by S. typhi (21%). S. flexneri (58.5%) and S. dysenteriae (36.7%) were the most frequently isolated species among the Shigella. Results of sensitivity testing to five commonly used antibiotics in the area: ampicillin, chloramphenicol, gentamicin, tetracycline and cotrimoxazole, showed multiple drug resistance among the isolates of both salmonella and shigella. Only 4% of shigella were sensitive to all five antibiotics screened for in the study. Overall sensitive of shigella isolates to individual antibiotics was 8.8% to tetracycline, 10% to ampicillin, 28% to co-trimoxazole and 98% to gentamicin. No resistance was observed to nalidixic acid among 108 shigella strains tested for this antibiotic. The continued sensitivity of S. typhi to chloramphenicol, cotrimoxazole, ampicillin and the other commonly used antibiotics is noted. It is recommended that nalidixic acid be introduced into the area under strict regulation for treatment of severe cases of shigella dysentery, an illness which is highly endemic in the region and the cause of occasional epidemics with high mortality.

Entities:  

Mesh:

Year:  1997        PMID: 9557442

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  8 in total

Review 1.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

Authors:  P K Ram; J A Crump; S K Gupta; M A Miller; E D Mintz
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

2.  Epidemiological, clinical features and susceptibility pattern of shigellosis in the buea health district, Cameroon.

Authors:  Anna L Njunda; Jules Cn Assob; Dickson S Nsagha; Henri Lf Kamga; Maghah P Awafong; Elroy P Weledji
Journal:  BMC Res Notes       Date:  2012-01-21

3.  Intestinal parasitosis and shigellosis among diarrheal patients in Gondar teaching hospital, northwest Ethiopia.

Authors:  Kahsay Huruy; Afework Kassu; Andargachew Mulu; Netsanet Worku; Teshome Fetene; Simon Gebretsadik; Fantahun Biadglegne; Yeshambel Belyhun; Abebe Muche; Aschalew Gelaw; Belay Anagaw; Sisay Yifru; Yemataw Wondie; Assegedech Bekele; Moges Tiruneh; Dieter Reissig; Feleke Moges
Journal:  BMC Res Notes       Date:  2011-10-31

4.  A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better?

Authors:  Sylvia Omulo; Samuel M Thumbi; M Kariuki Njenga; Douglas R Call
Journal:  Antimicrob Resist Infect Control       Date:  2015-01-28       Impact factor: 4.887

Review 5.  A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014).

Authors:  Ifeanyi Valentine Uche; Calman A MacLennan; Allan Saul
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

6.  Epidemiologic Investigation of Dysentery in North of Iran: Use of Geographic Information System (GIS).

Authors:  Aliasghar Nadi; Ghassem Abedi; Khatoon Isazadeh; Farideh Rostami; Hasan Siamian; Mahbobeh Hosseini; Mehran Asadi-Aliabadi
Journal:  Mater Sociomed       Date:  2016-12

7.  Prevalence and antimicrobial susceptibility of Salmonella and Shigella species isolated from diarrheic children in Ambo town.

Authors:  Wagi Tosisa; Adane Mihret; Asnake Ararsa; Tadesse Eguale; Tamrat Abebe
Journal:  BMC Pediatr       Date:  2020-02-27       Impact factor: 2.125

8.  Prevalence of intestinal parasite, Shigella and Salmonella species among diarrheal children in Jimma health center, Jimma southwest Ethiopia: a cross sectional study.

Authors:  Getenet Beyene; Haimanot Tasew
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-02-05       Impact factor: 3.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.